Instrument-manufacturing executive — EB-1C approved one month after filing

S Instruments is a substantial manufacturer in China with production facilities, an in-house R&D base, and over a hundred employees. In 2022 the company decided to establish a U.S. subsidiary and dispatch Mr. A. as its senior executive. Because the U.S. entity began as a growth-stage operation, we structured the path as L-1A New Office → L-1A extension → EB-1C.

Timeline: - April 2022: U.S. company incorporated. - June 2022: New Office L-1A filed; approved August 2022 with one-year validity. - 2023: L-1A extension filed and approved (two-year validity). - October 2024: EB-1C I-140 filed. - November 2024: EB-1C I-140 approved.

The approval was a function of designing the company structure, the executive role definition, and the evidentiary record from the L-1A New Office stage forward — building a record that continuously satisfied multinational-executive criteria as the U.S. operation matured. By the time of the EB-1C filing, the U.S. subsidiary had a stable employee base, demonstrated revenue, and a clean managerial chain that supported the petition without significant rework.